← Back to Clinical Trials
Recruiting NCT07723157

NCT07723157 Cesarean Scar Defect: a Prospective, Observational Study.

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07723157
Status Recruiting
Phase —
Sponsor Medical University of Gdansk
Condition Niche
Study Type OBSERVATIONAL
Enrollment 150 participants
Start Date 2024-10-01
Primary Completion 2026-10-01

Eligibility & Interventions

Sex Female only
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Transvaginal ultrasonography examination

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 150 participants in total. It began in 2024-10-01 with a primary completion date of 2026-10-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The study is conducted as part of the doctoral thesis of Natalia Mazur-Ejankowska, a medical doctor undergoing specialist training in obstetrics and gynecology at the Department of Obstetrics and Gynecology, Gynecologic Oncology, and Gynecologic Endocrinology at the University Clinical Centre in Gdańsk, Poland, where the research will be carried out at every stage. The aim of the study is to evaluate the cesarean section scar and the lower uterine segment after first cesarean section, and to assess risk factors, symptoms, and epidemiological data in patients enrolled to the study.

Eligibility Criteria

Inclusion Criteria: * patient consent * patient age over 18 years of age * first cesarean section after 26 weeks of gestation Exclusion Criteria: * lack of patient consent * patient age under 18 years * cesarean section before 26 weeks of gestation

Contact & Investigator

Central Contact

Natalia K Mazur-Ejankowska, Medical Doctor

✉ natalia.mazur@gumed.edu.pl

📞 +48 58 584 4100

Principal Investigator

Magdalena E Grzybowska, Medical Doctor

STUDY DIRECTOR

Division of Gynecology and Obstetrics, Medical University of Gdańsk

Frequently Asked Questions

Who can join the NCT07723157 clinical trial?

This trial is open to female participants only, aged 18 Years or older, studying Niche. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07723157 currently recruiting?

Yes, NCT07723157 is actively recruiting participants. Contact the research team at natalia.mazur@gumed.edu.pl for enrollment information.

Where is the NCT07723157 trial being conducted?

This trial is being conducted at Gdansk, Poland.

Who is sponsoring the NCT07723157 clinical trial?

NCT07723157 is sponsored by Medical University of Gdansk. The principal investigator is Magdalena E Grzybowska, Medical Doctor at Division of Gynecology and Obstetrics, Medical University of Gdańsk. The trial plans to enroll 150 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology